CPT code 83036 is the code labs and physician offices use to bill a Hemoglobin A1c (HbA1c) test, the blood test that shows a patient’s average glucose control over roughly the past two to three months. If you code for a primary care, endocrinology, or internal medicine practice, you’ll see this code on nearly every diabetic patient’s chart. Getting the description, the ICD-10 pairing, and the frequency rules right is what separates a clean claim from a denial.
What Is CPT Code 83036?
The short descriptor for CPT code 83036 is “Hemoglobin; glycosylated (A1c).” It covers a quantitative laboratory measurement of glycated hemoglobin using methods such as high-performance liquid chromatography (HPLC), immunoassay, or enzymatic analysis. The code applies regardless of where the sample is drawn. A hospital lab, a reference lab, and a physician office lab all bill 83036 when the testing method is a standard laboratory platform rather than an FDA-cleared home-use device.
83036 sits in the pathology and laboratory section of the CPT code set. Coders typically pair it with an evaluation and management code or a preventive visit code from the same encounter, plus the ICD-10 code that documents why the physician ordered the test.
What the HbA1c Test Actually Measures
An HbA1c test measures the percentage of hemoglobin in a blood sample that has glucose attached to it. Because red blood cells live for roughly three months, the result reflects average blood sugar over that window rather than a single point-in-time reading like a fasting glucose test. Physicians order it to diagnose diabetes, to check whether a current treatment plan is working, and to screen patients who show risk factors for prediabetes.
For coders, the clinical purpose matters because it drives the ICD-10 pairing. A test ordered to diagnose new-onset diabetes needs a different diagnosis code than one ordered to monitor an existing, well-controlled patient, even though both use CPT 83036.
CPT 83036 vs. CPT 83037: What’s the Difference?
CPT 83036 and CPT 83037 both bill an A1c test, and mixing them up is one of the most common medical coding services errors on lab claims. The difference comes down to where and how the test runs, not what it measures.
| Factor | CPT 83036 | CPT 83037 |
|---|---|---|
| What It Covers | A1c test performed on a standard laboratory platform, such as HPLC, immunoassay, or an enzymatic method | A1c test performed using an FDA-cleared device intended for home use |
| Typical Setting | Hospital laboratory, reference laboratory, or physician-office laboratory | Patient’s home or point-of-care setting using the qualifying device |
| CLIA Requirement | Depends on the certificate held by the laboratory performing the test | Typically requires a CLIA Certificate of Waiver |
| Common Modifier | QW when the laboratory holds a Certificate of Waiver and the specific test requires it | QW when the laboratory holds a Certificate of Waiver and payer rules require it |
If your practice runs A1c tests on a standard in-office analyzer that doesn’t carry FDA home-use clearance, 83036 is almost always the correct code, even though the test happens in the office rather than at a reference lab.
ICD-10 Codes That Support Medical Necessity
CPT 83036 needs an ICD-10 code that documents why the physician ordered the test. The pairings that show up most often include:
- E10.9 — Type 1 diabetes mellitus without complications
- E11.9 — Type 2 diabetes mellitus without complications
- E11.29 — Type 2 diabetes with diabetic chronic kidney disease
- E11.319 — Type 2 diabetes with unspecified diabetic retinopathy
- R73.03 — Prediabetes
- O24.4– — Gestational diabetes mellitus (coded to trimester)
Coverage policies vary by Medicare Administrative Contractor and by commercial payer, so treat this as a starting point rather than a substitute for checking the current local coverage determination. Understanding how ICD-10 and CPT codes work together matters here specifically, because 83036 alone rarely establishes medical necessity. The diagnosis code does that work.
How Often Can CPT 83036 Be Billed?
Medicare’s glycated hemoglobin coverage policy, NCD 190.21, generally supports A1c testing about twice a year for diabetic patients whose treatment is stable, and up to once every three months for patients whose treatment has recently changed or whose glucose control isn’t meeting target. Testing beyond that window is still payable when the chart documents the clinical reason, but claims that exceed the frequency limit without that documentation are a common source of denials.
Frequency edits like this are a routine part of medical billing services for any practice with a diabetes-heavy panel, since a single missed edit can affect months of claims before anyone notices the pattern. Commercial payers publish their own frequency policies, and they don’t always match Medicare’s. Verifying the specific payer’s policy before scheduling a patient’s next A1c test is worth the two minutes it takes.
Modifiers Commonly Used with CPT 83036
Two modifiers show up regularly on CPT 83036 claims. Modifier QW tells the payer the test ran on a CLIA-waived analyzer under a Certificate of Waiver; practices that hold a Certificate of Compliance or Accreditation instead should leave QW off. Modifier 91 applies only when the lab repeats the same A1c test on the same patient on the same day to capture a new, distinct result, not when a lab simply reruns a failed or invalid sample.
Prevent CPT 83036 Coding and Modifier Errors
Mixing up CPT 83036 and 83037—or omitting the QW modifier when required—is one of the fastest ways an HbA1c claim gets denied or underpaid. Our coding specialists review laboratory codes against payer-specific frequency and modifier rules before submission, catching errors in-house instead of on an EOB.
How CPT 83036 Is Reimbursed
CPT 83036 is priced under the Clinical Laboratory Fee Schedule (CLFS) rather than the Medicare Physician Fee Schedule, which is why its payment sits well below an E/M or procedural code. CMS updates CLFS rates annually, and the exact amount your practice sees depends on your Medicare Administrative Contractor and geographic locality, so it’s worth checking the CMS CLFS lookup tool directly rather than relying on a number from a blog post. Commercial payers set their own rates by contract, and those rates typically move independently of Medicare’s.
Because the per-test payment is modest, the real financial risk with 83036 isn’t the rate, it’s volume. A practice running A1c tests on every diabetic patient at every visit accumulates denials fast if the code, modifier, or ICD-10 pairing is wrong even a small percentage of the time. That’s where a disciplined revenue cycle management process pays for itself, catching pattern-level errors before they compound across hundreds of claims a month.
Common Reasons CPT 83036 Claims Get Denied
Most 83036 denials trace back to one of five issues:
- Code confusion — billing 83036 for a test actually run on an FDA-cleared home-use device (which belongs under 83037), or the reverse
- ICD-10 mismatch — attaching a diagnosis code that doesn’t establish medical necessity for glycemic testing
- Frequency limit exceeded — billing more tests in a coverage period than the payer allows, without documentation showing a treatment change or uncontrolled glucose
- Missing or incorrect modifier — leaving QW off a CLIA-waived test, or applying modifier 91 to a claim that wasn’t actually a same-day repeat
- Duplicate billing — submitting 83036 more than once for the same patient on the same date of service, when only one unit is payable
These issues echo the same patterns behind the reasons insurance claims get denied across other lab and diagnostic codes, which is why a coding review process that catches them before submission tends to outperform one that only catches them on appeal.
Documentation Checklist for CPT 83036
Before submitting a claim with CPT 83036, confirm the chart supports:
- A physician’s order for the A1c test, dated and signed
- A diagnosis code that documents diabetes, prediabetes, or another condition the payer recognizes as medical necessity
- The testing method or analyzer used, so the coder can confirm 83036 (not 83037) is correct
- The date of the patient’s last A1c test, if billing inside the standard frequency window
- A brief note justifying more frequent testing, when applicable — for example, a recent medication change or an out-of-range result
- The CLIA certificate type on file for the performing lab, which determines whether modifier QW applies
The Bottom Line
CPT code 83036 looks simple on paper: one test, one code, run it every few months. The denials show up in the details, the wrong code for the testing method, a diagnosis that doesn’t support medical necessity, a missing modifier, or a frequency edit nobody caught before the claim went out. Getting those details right on every A1c claim is a small, repeatable habit that adds up to real revenue across a full patient panel.
Stop Preventable HbA1c Claim Denials
Denials on high-volume laboratory codes such as CPT 83036 rarely come from poor clinical care. They usually result from a code, modifier, or ICD-10 pairing that does not match the payer’s requirements. Docscare’s certified coders manage that matching for practices performing frequent A1c testing, helping prevent revenue from leaking through avoidable rejections.
Frequently Asked Questions
What does CPT code 83036 mean?
CPT code 83036 reports a Hemoglobin A1c (HbA1c) test performed with a standard laboratory method, such as HPLC or immunoassay. It measures the percentage of hemoglobin coated with glucose, which reflects a patient’s average blood sugar control over roughly two to three months.
What is the official CPT code 83036 description?
The CPT code set describes 83036 as “Hemoglobin; glycosylated (A1c).” Coders use this descriptor to distinguish 83036 from 83037, which applies specifically to A1c testing performed on an FDA-cleared home-use device.
Is CPT 83036 the same as CPT 83037?
No. Both codes bill an A1c test, but 83036 applies to lab-based testing platforms, while 83037 applies only when the test runs on a device the FDA has cleared for home use. Billing 83037 for a standard lab analyzer is a common cause of denials.
How often will Medicare pay for CPT 83036?
Under Medicare’s glycated hemoglobin coverage policy (NCD 190.21), stable diabetic patients are typically covered for A1c testing about twice a year, while patients with a recent treatment change or uncontrolled glucose can qualify for testing as often as every three months when the documentation supports it.
What ICD-10 codes pair with CPT 83036?
Common pairings include E10.9 and E11.9 for diabetes without complications, E11.29 and E11.319 for diabetes with kidney or eye complications, R73.03 for prediabetes, and the O24.4 series for gestational diabetes. Coverage varies by payer, so verify against the current local coverage determination.
Does CPT 83036 need a modifier?
Not always, but many CLIA-waived office labs append modifier QW to show the test ran on a CLIA-waived analyzer. Modifier 91 applies only when the lab repeats the same A1c test on the same patient, same day, to capture a new result rather than to confirm the first one.
Why do CPT 83036 claims get denied most often?
The leading causes are billing 83036 when 83037 applies (or the reverse), an ICD-10 code that doesn’t establish medical necessity, testing more often than the payer’s frequency limit without supporting documentation, and a missing or incorrect QW modifier on a CLIA-waived test.
